http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106367390-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0619 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0793 |
filingDate | 2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106367390-B |
titleOfInvention | Neuron cell culture solution and culture method |
abstract | The invention discloses a culture solution for culturing neuron cells based on peripheral blood mononuclear cells, which comprises: DMEM/F12 basal medium and nerve cell culture medium with the volume ratio of 1: 0.8-1.2, nerve growth factor, adenylate cyclase activator, serum substitute, L-ascorbic acid, L-glutamine derivative, ALK inhibitor, GSK-3 beta inhibitor, GSK3 alpha inhibitor, ALK-2,3,6, AMPK inhibitor and TGF-beta R inhibitor. The invention also discloses a method for culturing the neuron cells by using the peripheral blood mononuclear cells, the neuron cells can be obtained by using the culture solution through directional differentiation culture by using the peripheral blood mononuclear cells as raw materials, the materials are convenient to obtain, the quantity is not limited, and moral disputes can be avoided. |
priorityDate | 2016-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 238.